Singapore markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
131.19+0.31 (+0.24%)
At close: 04:00PM EDT
132.37 +1.18 (+0.90%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close130.88
Open130.69
Bid131.20 x 1000
Ask130.83 x 800
Day's range129.81 - 131.32
52-week range99.14 - 133.10
Volume6,956,134
Avg. volume8,218,136
Market cap332.279B
Beta (5Y monthly)0.40
PE ratio (TTM)144.16
EPS (TTM)0.91
Earnings date30 Jul 2024
Forward dividend & yield3.08 (2.35%)
Ex-dividend date14 Mar 2024
1y target est141.42
  • Simply Wall St.

    Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness

    The fact that multiple Merck & Co., Inc. ( NYSE:MRK ) insiders offloaded a considerable amount of shares over the past...

  • Zacks

    5 Stocks Powering the Dow ETF Year to Date

    The Dow Jones touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts. We have highlighted five ETFs that have been leading the way higher this year.

  • Benzinga

    Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

    On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose France” business summit. Together with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87 billion which is more than $2 billion to expand their operations in the country. AstraZeneca committed 365 million euros, which is about $394 mi